Rate dependent effects of procainamide on the threshold current for pacing in the setting of postrepolarization refractoriness in dogs

PACE - Pacing and Clinical Electrophysiology

Volumn 22, Issue 2, 1999, Pages 291-301

  Leerssen, Hendrik M ^a   Vos, Mark A ^a   Den Bulk, Karel ^a   Van Der Zande, Jolanda ^a   Wellens, Hein J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Action potential duration; Postrepolarization refractoriness; Procainamide; Rate dependency; Threshold current; Ventricular effective refractory period

Indexed keywords

PROCAINAMIDE;

AMPEROMETRY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; ATRIOVENTRICULAR BLOCK; CONTROLLED STUDY; CORRELATION FUNCTION; DOG; DRUG EFFECT; DRUG INFUSION; FEMALE; HEART ELECTROPHYSIOLOGY; HEART MUSCLE EXCITABILITY; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART RATE; HEART VENTRICLE PACING; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN;

EID: 0032975460     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1999.tb00441.x     Document Type: Article

References (43)

1. 1. Hoffman BF, Cranefield PF, Lepeschkin E, et al. Comparison of cardiac monophasic action potentials recorded by intracellular and suction electrodes. Am J Physiol 1959; 196:1297-1301.
2. 2. Korsgren M, Leskinen E, Sjostrand U. Intracardiac recording of monophasic action potentials in the human heart. Scand J Clin Lab Invest 1966; 18: 561-564.
3. 3. Franz MR. Long-term recording of monophasic action potentials from human endocardium. Am J Cardiol 1983; 51:1629-1634.
4. 4. Yuan S, Blomström-Lundqvist C, Olsson SB. Monophasic action potentials: Concepts to practical applications. J Cardiovasc Electrophysiol 1994; 5:287-308.
5. 5. Costard-Jaeckle A, Franz MR. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo. J Pharmacol Exp Ther 1989; 251:39-46.
6. 6. Nademanee K, Stevenson WG, Weiss JN, et al. Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans. Circulation 1990; 81:790-796.
7. 7. Franz MR, Chin MC, Sharkey HR, et al. A new single catheter technique for simultaneous measurement of action potential duration and refractory period in vivo. J Am Coll Cardiol 1990; 16:878-886.
8. 8. Lazzara R, El-Sherif N, Scherlag BJ. Disorders of cellular electrophysiology produced by ischemia of the canine His bundle. Circ Res 1975; 36:444-454.
9. 9. Davidenko JM, Antzelevitch C. Electrophysiological mechanisms underlying rate-dependent changes of refractoriness in normal and segmentally depressed canine Purkinje fibers. The characteristics of post-repolarization refractoriness. Circ Res 1986; 58:257-268.
10. 10. Camardo JS, Greenspan AM, Horowitz LN, et al. Strength-interval relation in the human ventricle: Effect of procainamide. Am J Cardiol 1980; 45:856-860.
11. 11. Franz MR, Costard A. Frequency-dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ. Circulation 1988; 77:1177-1184.
12. 12. Nakaya Y, Nii H, Nomura M, et al. Effects of lidocaine and quinidine on post-repolarization refractoriness after the basic and premature action potentials: Consideration of aim of antiarrhythmic drug therapy. Am Heart J 1989; 118:907-912.
13. 13. Lee RJ, Liem LB, Cohen TJ, et al. Relation between repolarization and refractoriness in the human ventricle: Cycle length dependence and effect of procainamide. J Am Coll Cardiol 1992; 19:614-618.
14. 14. Janse MJ, van der Steen ABM, van Dam RT, et al. Refractory period of the dog's ventricular myocardium following sudden changes in frequency. Circ Res 1969; 24:251-262.
15. 15. Greenspan AM, Camardo JS, Horowitz LN, et al. Human ventricular refractoriness: Effects of increasing current. Am J Cardiol 1981; 47:244-250.
16. 16. Morady F, Kadish AH, Kushner JA, et al. Comparison of ventricular refractory periods determined by incremental and decremental scanning of an extrastimulus. PACE 1989; 12(Pt. I):546-554.
17. 17. Morady F, Kadish AH, Rosenheck S, et al. Effect of the intertrain pause on the ventricular effective refractory period measured by the extrastimulus technique. PACE 1990; 13:405-409.
18. 18. Kadish AH, Kou WH, Schmaltz S, et al. Effect of atrioventricular relationship on ventricular refractoriness in humans. Am J Physiol 1990; 259: H1463-H1470.
19. 19. Kadish AH, Schmaltz S, Morady F. Variability in the measurement of human ventricular refractoriness. PACE 1991; 14:1393-1401.
20. 20. Langberg JL, Calkins H, Sousa J, et al. Effects of drive train stimulus intensity on ventricular refractoriness in humans. Circulation 1991; 84:181-187.
21. 21. Leerssen HM, Vos MA, den Dulk K, et al. Is the ventricular effective refractory period different when determined by incremental versus decremental scanning? The effect of pacing cycle length, d-sotalol, and levcromakalim. PACE 1994; 17(Pt. II):2084-2089.
22. 22. Scherlag BJ, Kosowsky BD, Damato AN. A technique for ventricular pacing from the His bundle in the intact heart. J Appl Physiol 1967; 22:584-587.
23. 23. Kus T, Derakhchan K, Bouchard C, et al. Effects of procainamide on refractoriness, conduction, and excitable gap in canine atrial reentrant tachycardia. PACE 1991; 14(Pt. II):1707-1713.
24. 24. Ware DL, Atkinson JB, Brooks MJ, et al. Ventricular defibrillation in canines with chronic infarction, and effects of lidocaine and procainamide. PACE 1993; 16:337-346.
25. 25. Furman S, Hurzeler P, Mehra R. Cardiac pacing and pacemakers IV. Threshold of cardiac stimulation. Am Heart J 1977; 94:115-124.
26. 26. Koller BS, Karasik PE, Solomon AJ, et al. Relation between repolarization and refractoriness during programmed electrical stimulation in the human right ventricle. Circulation 1995; 91:2378-2384.
27. 27. Costard-Jaeckle A, Liem LB, Franz MR. Frequency-dependent effect of quinidine, mexiletine, and their combination on postrepolarization refractoriness in vivo. J Cardiovasc Pharmacol 1989; 14:810-817.
28. 28. Hook BG, Perlman RL, Callans DJ, et al. Acute and chronic cycle length dependent increase in ventricular pacing threshold. PACE 1992; 15(Pt. I): 1437-1444.
29. 29. Kastor JA, Josephson ME, Guss SB, et al. Human ventricular refractoriness II. Effects of procainamide. Circulation 1977; 56:462-467.
30. 30. Edvardsson N, Hirsch I, Olsson SB. Acute effects of lignocaine, procainamide, metropolol, digoxin and atropine on human myocardial refractoriness. Cardiovasc Res 1984; 18:463-470.
31. 31. Barold SS, McVenes R, Stokes K. Effect of drugs on pacing threshold in man and canines: Old and new facts. In SS Barold, J Mugica (eds.): New Perspectives in Cardiac Pacing. Vol. 3, Armonk, NY, Futura Publishing Company, 1993, pp. 57-83.
32. 32. Woske H, Belford J, Fastier FN, et al. The effect of procaine amide on excitability, refractoriness and conduction in the mammalian heart. J Pharmacol Exp Ther 1953; 107:134-140.
33. 33. Gay RJ, Brown DF. Pacemaker failure due to procainamide toxicity. Am J Cardiol 1974; 34:728-732.
34. 34. Mehta J, Khan AH. Pacemaker Wenckebach phenomenon due to antiarrhythmic drug toxicity. Cardiology 1976; 61:189-194.
35. 35. Marchlinski FE, Shinnar M. Cycle length dependent effects of procainamide on ventricular refractoriness, (abstract) J Am Coll Cardiol 1987; 9:227A.
36. 36. Joyner RW, Ramza BM, Osaka T, et al. Cellular mechanism of delayed recovery of excitability in ventricular tissue. Am J Physiol 1991; 260:H225-H233.
37. 37. Whalley DW, Wendt DJ, Grant AO. Basic concepts in cellular cardiac electrophysiology: Part I: Ion channels, membrane currents, and the action potential. PACE 1995; 18:1556-1574.
38. 38. Vos MA, de Groot SHM, Verduyn SC, et al. Enhanced susceptibility for aquired Torsade de Pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling. Circulation 1998;98: 1125-1135.
39. 39. Kay GN, Mulholland DH, Epstein AE, et al. Effect of pacing rate on the human atrial strength-duration curve. J Am Coll Cardiol 1990; 15:1618-1623.
40. 40. Hoffman BF, Cranefield PF. Electrophysiology of the Heart. New York, McGraw-Hill, 1960, pp. 211-256.
41. 41. Shimizu W, Ohe T, Kurita T, et al. Early afterdepolarizations induced by isoproterenol in patients with congenital long QT syndrome. Circulation 1991; 84:1915-1923.
42. 42. Verduyn SC, Vos MA, van der Zande J, et al. Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: Reversal by magnesium. Cardiovasc Res 1997; 34:453-463.
43. 43. Antzelevitch C, Sicouri S, Lukas A, et al. Regional differences in the electrophysiology of ventricular cells: Physíological and clinical implications. In MD Zipes, J Jalife (eds.): Cardiac Electrophysiology. From Cell to Bedside, Philadelphia, W. B. Saunders Company, 1995, pp. 228-245.